Trial NCT01445587

View at ClinicalTrials.gov 
Org. Study IDs: 115340

Last trial update was posted on 2012-03-26

MeSH Interventions

Bortezomib

MeSH Conditions

Multiple Myeloma Neoplasms, Plasma Cell

Other Conditions

Cancer

Stopping Reasons

Based on the clinical activity, not safety data, of the AKT inhibitor, GSK has decided at this time to suspend further development of GSK2110183 as monotherapy.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID